Results 71 to 80 of about 20,498,806 (233)
Three years of ocular proton therapy in the Netherlands, clinical results
Abstract Purpose Uveal melanoma (UM) is a rare cancer with rising number of diagnosis (143 diagnoses in 1990 to 226 in 2023) in the Netherlands. Most patients are treated locally with Ruthenium‐106 brachytherapy (±102/year). Patients were referred for proton therapy (PT) to Switzerland in the past, but PT is available in the Netherlands from January ...
C. Rasch +14 more
wiley +1 more source
Radiobiological Effects for Prostate Cancer High-Dose-Rate Brachytherapy
Background: HDR brachytherapy represents a cornerstone in prostate cancer management by enabling high tumor doses while sparing surrounding normal tissues.
Alaa A. Abou Khadra +3 more
doaj +1 more source
Transurethral ultrasound ablation (TULSA) for prostate cancer: a systematic review and meta‐analysis
Objective Our objective was to synthesise evidence on oncological, functional and safety outcomes of magnetic resonance imaging‐guided transurethral ultrasound ablation (TULSA) for primary and recurrent prostate cancer. Methods MEDLINE, Embase, Web of Science and Scopus were systematically searched from inception to July 2025. The primary outcomes were
Eugene Wang +4 more
wiley +1 more source
High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers
International audienceThe purpose of this study was to analyze and compare clinical outcomes of low-dose-rate (LDR) and high-dose-rate (HDR) interstitial brachytherapy boost (ISBT) after EBRT or radio chemotherapy for the treatment of anal canal ...
Giovaninni, Marc +12 more
core +1 more source
Sexual and relational challenges in men and women affected by prostate cancer: a Project SEXUS study
Objectives To examine, in a nationally representative Danish study, a comprehensive range of sexual characteristics, dysfunctions and relational challenges among men with prostate cancer (PCa) aged ≥50 years and women married to such men, compared with unaffected men and women.
Ingrid Josefine Lundorff +4 more
wiley +1 more source
Radical radiotherapy is one of the options for the management of prostate cancer. In external beam therapy, 3D conformal radiotherapy (3DCRT) and intensity modulated radiotherapy (IMRT) are the options for delivery of increased radiation dose, as vital ...
Murali V +3 more
doaj
Purpose: To evaluate clinical outcomes and toxicity of definitive interstitial or hybrid interventional radiotherapy (IRT; brachytherapy) using high-dose-rate (HDR) or pulsed-dose-rate (PDR) techniques for non-melanoma skin cancer (NMSC) unsuitable for ...
Artur J. Chyrek +7 more
doaj +1 more source
ABSTRACT Introduction Head and neck oncologic outcomes can be negatively affected by diagnostic delays. This study aimed to assess diagnostic delays and differences in treatment intensity associated with antibiotic prescribing prior to head and neck cancer.
Austin T. Armstrong +5 more
wiley +1 more source
Purpose: The goal is to develop a stand-alone application, which automatically and consistently computes the coordinates of the dose calculation point recommended by the American Brachytherapy Society (i.e., point A) based solely on the implanted ...
Hyejoo Kang +3 more
core +1 more source
Purpose: To compare health-related quality of life (HRQOL) of high-dose-rate brachytherapy (HDRB) versus low dose-rate brachytherapy (LDRB) for localized prostate cancer in a multi-institutional phase 2 randomized trial.
Lara Hathout, MD, FRCPC +12 more
doaj +1 more source

